Literature DB >> 24210442

Gestational trophoblastic disease.

Alampady K P Shanbhogue1, Neeraj Lalwani, Christine O Menias.   

Abstract

Imaging plays a crucial role in diagnosis and management of gestational trophoblastic disease. Ultrasonography is the initial investigation of choice for the diagnosis. Pelvic magnetic resonance (MR) imaging is used as a problem-solving tool for assessment of degree of local invasion. Chest radiography is the recommended initial radiographic staging modality, and chest computed tomography is performed if the radiograph is negative. (18)F-Fluorodeoxyglucose positron emission tomography has been shown to be useful in assessing the active or viable sites of metastases, thereby determining the need for tumor resectability in chemoresistant disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Choriocarcinoma; Hydatidiform mole; Magnetic resonance imaging

Mesh:

Substances:

Year:  2013        PMID: 24210442     DOI: 10.1016/j.rcl.2013.07.011

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  4 in total

1.  40-year-old female with menorrhagia and abdominal pain: A case of metastatic gestational trophoblastic neoplasia.

Authors:  Bhavraj Khalsa; Chandana Lall; Roozbeh Houshyar; John Fox
Journal:  Radiol Case Rep       Date:  2015-12-03

2.  Ultrasound diagnosis of molar pregnancy.

Authors:  Jackie A Ross; Alina Unipan; Jackie Clarke; Catherine Magee; Jemma Johns
Journal:  Ultrasound       Date:  2018-03-02

Review 3.  Gestational trophoblastic disease: a multimodality imaging approach with impact on diagnosis and management.

Authors:  Sunita Dhanda; Subhash Ramani; Meenkashi Thakur
Journal:  Radiol Res Pract       Date:  2014-07-13

Review 4.  Clinical and radiological correlations in patients with gestational trophoblastic disease.

Authors:  Lana de Lourdes Aguiar Lima; Raphael Câmara Medeiros Parente; Izildinha Maestá; Joffre Amim Junior; Jorge Fonte de Rezende Filho; Carlos Antonio Barbosa Montenegro; Antônio Braga
Journal:  Radiol Bras       Date:  2016 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.